Clinical Pharm Specialist \u2013Hema/Onc and Gen Inf SCH

Responsibilities

• Works with the System Director of Pharmacy Services, system and site pharmacy leadership in the establishment and maintenance of a comprehensive, patient focused clinical pharmacy services program specializing in Hematology/Oncology and General Infusion Therapy.
• Collaborates with Oncologists, non-physician practitioners, nursing staff, and infusion center/Pharmacy leadership in the optimization of patient care by promoting rational, safe, and cost-effective drug therapy.
• Conducts drug therapy monitoring and drug formulary reviews, implements drug therapy interventions to reduce adverse events.
• Participates in various research projects including oncology and may conduct pharmacy practice research.
• Provides educational programs and training for nurses, pharmacists and pharmacy staff, medical and pharmacy residents, physicians, non-physician practitioners, other members of the healthcare team as well as patients and their families.
• May be required to provide non-clinical/operation support Precepting pharmacy residents and students as required from across the system.
• May be required to provide consultations and/or clinical pharmacy services for inpatient hematology/oncology patients and/or other system infusion sites and inpatient facilities as needed.
• Aids System Director of Pharmacy, system, and site pharmacy leadership in maintenance of readiness by regulatory agencies and in ongoing compliance with all statutory regulations.

Requirements

• Doctor of Pharmacy degree (PharmD) with PGY1 Pharmacy Residency in an acute care setting required.
• PGY2 Pharmacy Residency in Oncology or Hematology/Oncology preferred.
• Current PGY2 residents in oncology or hematology/oncology accepted for application.
• Board Certification in Oncology Pharmacy preferred, and required within one year of hire, CDTM required (see below), or PharmD with completion of a PGY-1 Pharmacy Residency in an acute care hospital.
• PGY1 rotations in Oncology/Hematology preferred.
• One year of full-time (or equivalent) experience in Oncology or Hematology/Oncology required.
• Board Certification in Oncology Pharmacy preferred, and required within one year of eligibility.
• CDTM required (see below)
• Residency requirements: Must be obtained through nationally recognized organizations such as the Board of Pharmacy Specialties (BPS); Candidates must be certified/registered in NY State to participate in CDTM at the time of hire or within 6 months of start date. All Pharmacy Residencies require American Society of Health-System Pharmacists (ASHP) accreditation or candidate status. Candidates currently enrolled in an accredited or candidate status pharmacy residency program are eligible to apply. Evidence of residency completion must be available prior to start date.
• Experience Requirements: Relevant past experience must have been obtained in entirety within three years of application. Required full-time equivalent experience may be accrued over two-year period.
• Board Certification in specialty area: Ongoing maintenance of board certification required.
• Collaborative Drug Therapy Management (CDTM) Requirement: PGY1 residency year counts as a year of clinical experience; PGY2 residency counts as second year of clinical experience.
• Within one year of hire, will be required to complete a certificate program in pharmacogenomics (e.g. AACP Applied Pharmacogenomics Certificate Program) to facilitate participation in a personalized medicine approach. Additional certificate programs or board certifications may be required in response to advancement in treatments and modalities or change in scope of services.
• Preceptor Requirement: Within 12 months of hire, maintains compliance with preceptor qualifications set forth by the American Society of Health-System Pharmacists (ASHP).

Qualifications

• Relevant past experience must have been obtained in entirety within three years of application.
• Required full-time equivalent experience may be accrued over two-year period.
• Board Certification in specialty area: Ongoing maintenance of board certification required.
• Collaborative Drug Therapy Management (CDTM) Requirement: PGY1 residency year counts as a year of clinical experience; PGY2 residency counts as second year of clinical experience.
• Within one year of hire, will be required to complete a certificate program in pharmacogenomics (e.g. AACP Applied Pharmacogenomics Certificate Program) to facilitate participation in a personalized medicine approach. Additional certificate programs or board certifications may be required in response to advancement in treatments and modalities or change in scope of services.
• Preceptor Requirement: Within 12 months of hire, maintains compliance with preceptor qualifications set forth by the American Society of Health-System Pharmacists (ASHP).